NCT03678883 2026-04-03
9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Phase 2 Active not recruiting
Actuate Therapeutics Inc.
Memorial Sloan Kettering Cancer Center
Merck Sharp & Dohme LLC
University Hospital Muenster
St. Jude Children's Research Hospital